Investigating tumor-host response dynamics in preclinical immunotherapy experiments using a stepwise mathematical modeling strategy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigating tumor-host response dynamics in preclinical immunotherapy experiments using a stepwise mathematical modeling strategy
Authors
Keywords
-
Journal
MATHEMATICAL BIOSCIENCES
Volume -, Issue -, Pages 109106
Publisher
Elsevier BV
Online
2023-11-05
DOI
10.1016/j.mbs.2023.109106
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical PET Imaging of Granzyme B Shows Promotion of Immunological Response Following Combination Paclitaxel and Immune Checkpoint Inhibition in Triple Negative Breast Cancer
- (2022) Tiara S. Napier et al. Pharmaceutics
- Immune‐checkpoint inhibitor therapy response evaluation using oncophysics‐based mathematical models
- (2022) Mustafa Syed et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Model-informed experimental design recommendations for distinguishing intrinsic and acquired targeted therapeutic resistance in head and neck cancer
- (2022) Santiago D. Cárdenas et al. npj Systems Biology and Applications
- Cytokine-Mediated Crosstalk between Immune Cells and Epithelial Cells in the Gut
- (2021) Mousumi Mahapatro et al. Cells
- The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
- (2021) Vincenzo Salemme et al. Frontiers in Oncology
- Hypoxia Supports Differentiation of Terminally Exhausted CD8 T Cells
- (2021) Nadia Bannoud et al. Frontiers in Immunology
- 18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition
- (2021) Kirsten M. Reeves et al. CLINICAL CANCER RESEARCH
- Anti-HER2 induced myeloid cell alterations correspond with increasing vascular maturation in a murine model of HER2+ breast cancer
- (2020) Meghan J. Bloom et al. BMC CANCER
- Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy
- (2020) Joseph D. Butner et al. Science Advances
- Imaging for Response Assessment in Cancer Clinical Trials
- (2020) Anna G. Sorace et al. SEMINARS IN NUCLEAR MEDICINE
- In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model
- (2019) Hanwen Wang et al. Royal Society Open Science
- Improving Cancer Immunotherapy by Targeting the Hypoxic Tumor Microenvironment: New Opportunities and Challenges
- (2019) Muhammad Zaeem Noman et al. Cells
- Experimentally-driven mathematical modeling to improve combination targeted and cytotoxic therapy for HER2+ breast cancer
- (2019) Angela M. Jarrett et al. Scientific Reports
- Increased vessel perfusion predicts the efficacy of immune checkpoint blockade
- (2018) Xichen Zheng et al. JOURNAL OF CLINICAL INVESTIGATION
- Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
- (2018) Marco B. Schaaf et al. Cell Death & Disease
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET Imaging
- (2018) Benjamin M. Larimer et al. CLINICAL CANCER RESEARCH
- Targeting cancer-related inflammation in the era of immunotherapy
- (2017) Kyohei Nakamura et al. IMMUNOLOGY AND CELL BIOLOGY
- Optimal Design for Informative Protocols in Xenograft Tumor Growth Inhibition Experiments in Mice
- (2016) Giulia Lestini et al. AAPS Journal
- Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer
- (2016) Anna G. Sorace et al. MOLECULAR IMAGING AND BIOLOGY
- Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology
- (2016) Mark J. Selby et al. PLoS One
- Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
- (2015) Muhammad Zaeem Noman et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Chemokines in Cancer
- (2014) M. T. Chow et al. Cancer Immunology Research
- Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
- (2013) M. J. Selby et al. Cancer Immunology Research
- Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
- (2012) Valerie Chew et al. Journal of Oncology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Tumor necrosis factor and cancer, buddies or foes?
- (2009) Xia Wang et al. ACTA PHARMACOLOGICA SINICA
- Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer
- (2009) Christina L. Roland et al. PLoS One
- Optimal Experimental Design for Parameter Estimation of a Cell Signaling Model
- (2009) Samuel Bandara et al. PLoS Computational Biology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started